Cell Fuel
Natural health product licensed in Canada
- Other names
- Cell Fuel Synergy
- Licence holder
- Optimum Health Vitamins & More
- NPN or DIN-HM
- 80078432
- Status
- Active licence
- Licence date
- 15 June 2017
- Revision date
- 25 October 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Microorganismes CoQ10 - Cellule entière pour biosynthèse | 50 milligramme | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 250 milligramme | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 100 milligramme | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 100 milligramme | Not calculated |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone disodium salt | 5 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of antioxidant(s)/Provides antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Helps to maintain and/or support cardiovascular health. Supports mitochondrial function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are taking antibiotics or nitroglycerin, do not use this product.
- Précautions et mises en garde
If you are pregnant or breastfeeding, do not use this product. If you have kidney stones, diabetes, liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood thinners or blood pressure medication. May cause mild gastrointestinal symptoms (abdominal cramps and diarrhoea), headache, and/or fatigue. If these symptoms persist or are severe, discontinue use.
- Effets indésirables connus
May cause digestive problems. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of serious low blood sugar).
Source
Official Health Canada record, licence 80078432
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.